Medical Article

I lived for nine years with ALS while navigating a healthcare system that routinely obscured my own medical reality. But I know that pain is only amplified for individuals without medical expertise like mine. The post We Have a Problem: Even Doctors Struggle to Navigate our Healthcare System appeared first on MedCity News.

Strategic planning for the upcoming measurement year should incorporate thorough communication between the health plan, its HEDIS vendor, and auditor.   The post Building a Foundation for HEDIS Success Amid Change appeared first on MedCity News.

Investing in nurses — by reimbursing them based on the value of their work — can improve job satisfaction thus reducing the churn rate and attracting more to the profession. The post Who Wins When Nurses Are Reimbursed for Care Delivery? appeared first on MedCity News.

Updated schema requirements are easy to mix up — here are a few simple solutions The post Common MRF Mistakes Hospitals Are Making in 2024 appeared first on MedCity News.

Tennessee lawmakers recently passed a bill banning PBMs from owning pharmacies in the state, though like a similar Arkansas law, it is expected to face legal challenges if enacted. The post Will Tennessee’s PBM Bill Face the Same Fate as Arkansas’ Law? appeared first on MedCity News.

Povetacicept, a Vertex Pharmaceuticals immunology drug designed to block two targets, met the main goal of a Phase 3 clinical trial in the rare kidney disease immunoglobulin A nephropathy. The fusion protein came from Vertex’s acquisition of Alpine Immune Sciences, and analysts say the drug has best-in-class potential. The post Vertex Pharma to Seek Speedy…

Bispecific antibodies are already available for treating multiple myeloma. FDA approval of Regeneron Pharmaceuticals’ new drug, Lynozyfic, comes with dosing flexibility that sets it apart from others in its class. The post FDA Approves Regeneron Multiple Myeloma Drug With Dosing Edge Over J&J and Pfizer Meds appeared first on MedCity News.